MedPath

Monitoring of Systemic or Organ Perfusion for Preterm Infants

Completed
Conditions
Infant, Premature
Hypotension
Hypoperfusion in Newborn
Necrotizing Enterocolitis of Newborn
Sepsis Newborn
Oliguria
Interventions
Device: NIRS (near Infra-red spectroscopy)
Registration Number
NCT03136172
Lead Sponsor
Inha University Hospital
Brief Summary

To investigate biomarker reflects systemic or specific organ perfusion well, we are going to the observational comparison study using several hemodynamic monitoring methods in the premature infants. It includes near-infrared spectroscopy (NIRS), pulse oximetry with perfusion index (PI) and pleth variability index (PVI) and functional echocardiography.

Detailed Description

Hemodynamic observational comparisons will be performed in 6 episodes below on each patient.

1. first 24 hours after birth

2. during red blood cell (RBC) transfusion: from 4 hours before to 4 hours after the transfusion

3. suspicion of necrotizing enterocolitis: from the suspicion point for 48 hours

4. suspicion of sepsis: from the suspicion point for 48 hours

5. oligouria (\< 1 mL/kg/hour of urine): for 48 hours

6. hypotension (mean blood pressure \< 30 mmHg): for 48 hours

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
85
Inclusion Criteria
  • premature infants with 32 weeks or less of gestational age or 1,500 g or less of birth weight
Read More
Exclusion Criteria
  • infants without the consent of their guardians
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Premature infantNIRS (near Infra-red spectroscopy)premature infants with 32 weeks or less gestational age or 1,500 g or less birth weight, who born in the Inha university hospital and admit to the neonatal intensive care unit of the Inha university hospital
Primary Outcome Measures
NameTimeMethod
Positive predictive value of each index on hypotensionfirst 24 hours after birth

Positive predictive value of each index which are recorded through the monitoring machines

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Inha University Hospital

🇰🇷

Incheon, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath